OSWEGO, N.Y. — Oswego Health says it has purchased the cobas 5800 System, which it describes as a fully automated molecular laboratory instrument.
It offers a flexible PCR testing product to enable “accurate and reliable” diagnosis of infectious diseases, including chlamydia, gonorrhea, COVID-19, and HPV testing, Oswego Health said in its Wednesday announcement.
The system is built to offer a fully automated workflow and offers an expanded onboard capacity, allowing labs to test multiple assays simultaneously. It takes about 2.5 hours to produce the first 24 results. With 24 more results ready every 60 minutes thereafter, cobas 5800 has the capability of delivering up to 144 results in 8 hours.
(Sponsored)
It’s Time for Your Business to Think About Year-End Tax Planning
As the year-end approaches, it’s time to take proactive steps to help lower your business’s taxes for 2024 and beyond. Deferring income and accelerating deductions to minimize taxes can be
Timekeeping Trap: Be Careful When “Rounding” an Employee’s Work Time
The Fair Labor Standards Act (FLSA) regulations do not require an employer to track and pay an employee for the exact number of minutes they actually work. As currently written,
Oswego Health says it’s the fourth health-care system in the country to purchase the cobas 5800 System.
